Sep 23, 2011 5:30pm EDT Immunovaccine Announces CEO Start Date, Grant of Options and Amendments to its Stock Option Plan
Jun 20, 2011 8:35am EDT FDA Approves Immunovaccine's Application for a Phase I/II Clinical Trial for an Ovarian Cancer Vaccine
Jun 01, 2011 8:32am EDT Immunovaccine Announces Immune Results from Phase I Trial for DPX-0907 Therapeutic Cancer Vaccine
May 31, 2011 8:32am EDT Immunovaccine Provides Clinical Update and Attends BioFinance, ASCO and EU Biopharmaceutical Conferences
